Search clinical trials for: GSK2798745

Total 6 results

GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema

Macular Edema

Australia, United States, New Zealand
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Terminated

A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough

Cough

United Kingdom
GlaxoSmithKline

Completed

A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart Failure

Heart Failure

United States
GlaxoSmithKline

Completed

A First Time in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Healthy Subjects and Stable Heart Failure Patients

Oedema, Pulmonary

United Kingdom
GlaxoSmithKline

Completed

A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets

Heart Failure, Congestive

United States
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Terminated

Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model

Healthy Volunteers

Germany

3

Subscribe